Michelle Snyder is a healthcare veteran but has worked in corporate venturing for the past three years after being recruited by pharmaceutical distribution and healthcare IT group McKesson as a partner for its McKesson Ventures unit.
Snyder came from healthcare software provider Welltok where she was chief marketing officer, but it was a stint as an entrepreneur in residence at venture firm Interwest Partners that whetted her appetite for VC. She also has the expertise to assist startups in their own marketing.
“Having spent so many years operating, I can be a really value-add board member because I know what it’s like to build a business and I know the different inflection points companies go through,” Snyder says.
“I think I can be helpful building the business in general, but, assuming my portfolio companies want additional thought-partners, I like to dig in on marketing strategy with the teams, helping them think about things like positioning and branding.”
Snyder is particularly interested in the care-at-home segment of the market and her five investments include Galileo and ReImagine Care. She looks forward to continuing to invest in innovative healthcare technology companies and also serving on public boards.
“I’ve been in healthcare for 25-plus years, and for me this is the most exciting time”
“I’ve been in healthcare for 25-plus years, and for me this is the most exciting time,” she says. “You finally have technology, AI and cloud technology at a point where it can actually make a difference in healthcare. You have the healthcare system getting to the point where we really have to focus on improving quality and getting cost out of the system.
“There is this perfect storm of factors, and I think covid really brought some of the inequities in the system to light, where many of the pressure points in the system were and where you could use technology to alleviate that and jump us ahead in terms of where we need to be.”
See the rest of our Top 50 Rising Stars for 2023 here.
